Cancer - SpringWorks Therapeutics, Inc.

Cancer

Status:

Active, open to accrual

ClinicalTrials.gov:

NCT06251310

A PHASE 1A/1B DOSE ESCALATION, DOSE EXPANSION STUDY OF SW-682 IN PARTICIPANTS WITH ADVANCED SOLID TUMORS ENRICHED FOR THOSE WITH HIPPO PATHWAY MUTATIONS

Drug

SW-682

Condition

Mesothelioma and advanced solid tumors